SUMMARY Plasma renin activity (PRA) increases after acidification of plasma or exposure of plasma to cold temperatures. The purpose of the present study is to evaluate the hypothesis that these increases of PRA reflect inactivation of circulating renin inhibiting factors. In each of eight normotensive subjects, mean PRA increased (p < 0.01) after acidification of plasma by acid dialysis (98%), after acidification of plasma by addition of HCI (47%), or after exposure of plasma to -4°C for 5 days (155%). Renin substrate-free plasma was obtained by passing plasma over Sephadex G-50-40. Both untreated plasma and the substrate-free extract of plasma inhibited the enzymatic activity of renin (p < 0.01); little or no inhibition occurred after addition of acidified plasma or the protein-free extract of acidified plasma to renin-renin substrate. After addition of exogenous renin to cold-exposed plasma, the rate of angiotensin I generation was greater than that in control plasma (p < 0.05), although renin substrate did not differ. These observations suggest that denaturation of a circulating renin inhibitor may contribute to increased PRA after acidification or cold exposure of plasma. In a separate experiment, the addition of polyunsaturated free fatty acids (linoleic and arachidonic) to renin-renin substrate inhibited angiotensin production, although no inhibition occurred after dialysis of these fatty acids against an acid buffer (pH 3.3). Prolonged exposure of linoleic acid to cold temperatures did not affect its capacity to inhibit renin. Thus, loss of long chain, unSaturated free fatty acids may contribute to increased PRA after acid dialysis of plasma but not to increased PRA after exposure of plasma to cold temperatures. 
R
ENIN is a proteolytic enzyme that cleaves a circulating alpha-2-globulin substrate to form the decapeptide angiotensin I. Several reports suggest that plasma contains inhibitors of the reaction between renin and its substrate. 19 Acetonesoluble neutral lipids extracted from plasma inhibit renin, 10 and we have recently demonstrated that physiologic concentrations of long chain, unsaturated fatty acids inhibit both the capacity of renin to. generate angiotensin in vitro and the pressor response to renin in vivo. 11 Thus, in addition to renin and renin substrate concentrations, the measurement of plasma renin activity (PRA) may be affected by circulating renin inhibitors. We have used the term renin reactivity to refer to the capacity of added renin to generate angiotensin I either after its addition to crude plasma or to a preparation of renin substrate. 10 The measurement of plasma renin reactivity (PRR) provides the opportunity to evaluate the effect of plasma on the enzymatic activity of added renin.
The enzymatic activity of endogenous renin increases either after acidification of plasma 1214 or after prolonged incubation of plasma at -4°C. 16 ' lf> Acid activation and cryoactivation have generally been attributed to the production of an enzymatically more active renin from a prorenin. The present series of experiments was designed to evaluate the hypothesis that increased PRA* after acidification or cold exposure is related to denaturation of a normally occurring renin inhibitor. In these experiments, PRR was compared before and after exposure of plasma either to pH 3.3 or to -4°C for 5 days.
Methods
Acid "Activation" of Plasma Renin Peripheral venous plasma was obtained from each of eight normotensive control subjects. One aliquot was acidified by the Skinner plasma renin concentration (PRC) procedure. 17 According to this procedure, plasma is dialyzed against a glycine buffer to pH 3.3 over 18 hours at 4°C, incubated at 32°C for 45 minutes and then dialyzed back to pH 7.4 against a phosphate buffer over 18 hours at 4°C. To control for an effect of dialysis itself, a second plasma aliquot was dialyzed against phosphate buffer at pH 7.4, incubated at 32°C for 45 minutes and again dialyzed against the same phosphate buffer. As another control for an effect of dialysis, an additional aliquot of plasma was acidified to pH 3.3 by dropwise addition of 1 N HC1, without dialysis. Plasma was incubated at this pH for 18 hours at 4°C and then at 32°C for 45 minutes. These samples were then adjusted to pH 7.4 by addition of 1 N NaOH and were again incubated for 18 hours at 4°C.
To determine if acidification denatures a renin inhibitor in plasma, untreated plasma and plasma acidified both by dialysis and by addition of HC1 were added to renin-renin substrate. A preparation of exogenous human substrate was diluted with 150 mM phosphate buffer (pH 7.4) to a final concentration of 1000 ng/ml; 200 //I of untreated plasma and 1.1 X 10' Goldblatt units (GU) of renin were added to 1 ml of this substrate solution, and the rate of angiotensin production was measured after 30-and 60-minute incubations at 37°C. Control incubations containing phosphate buffer instead of plasma were added to the same concentrations of substrate and enzyme, and the rate of angiotensin production was measured. Higher concentrations of untreated plasma were not added to renin-renin substrate because endogenous substrate was present in plasma and higher total substrate concentrations (endogenous substrate plus added substrate) affect the rate of angiotensin production.
Acidification of plasma to pH 3.3 denatures endogenous renin substrate 17 thus providing the opportunity to add higher concentrations of "substrate free" plasma to renin-renin substrate. A constant concentration of exogenous human substrate was added to acid dialyzed plasma (1000 ng/ml) and to HCl-treated plasma, after the pH was readjusted to 7.4. Exogenous substrate was also added to plasma dialyzed only at pH 7.4. After addition of substrate, to measure the activity of endogenous plasma renin (endogenous "PRA"), the concentrations of angiotensin I generated were measured after 30-and 60-minute incubations at 37°C and pH 7.4. In addition, the capacity of added renin to generate angiotensin I was also measured (plasma renin reactivity); after addition of substrate, a constant concentration of exogenous renin was added (1.1 X 10^' GU/ml), and the concentrations of angiotensin I produced were measured after 30-and 60-minute incubations at 37°C and pH 7.4. The activity of added enzyme was determined by subtracting the relatively small concentrations of angiotensin generated without added enzyme (endogenous "PRA") from the total concentrations of angiotensin produced in the presence of exogenous renin.
Sephadex Fractionation of Plasma
Conceivably, acidification of plasma may affect factors in plasma other than renin and renin substrate that may also influence the velocity of the renin reaction. To extract substrate from plasma without acidification, an additional aliquot of plasma was passed over Sephadex G-50-40 (superfine) columns. Pharmacia K15 (900 mm X 15 mm) columns were used. Between 3.5 to 4.0 g of Sephadex was swollen overnight and the columns were packed by gravity. Sodium chloride (0.9%) was used to equilibrate and elute the column. After the column bed settled to a constant height, 5 ml of plasma sample was placed on the column, taking care not to displace the top of the gel bed. Fractions were collected from the time of application of the sample. The protein separation was monitored by reading the absorbancc of the eluate at 280 m^, and the protein peak was separated from the rest of the collected eluate. More than 97% of plasma protein (measured by the Lowry procedure) was removed by this fractionation procedure. The pooled eluate without protein was dialyzed (pore size 13,000) against water, lyophilized and taken up in 0.15 M phosphate buffer (pH 7.4) to the original sample volume. This eluate contained no measurable renin or renin substrate. The PRR was measured in these aliquots after addition of homologous substrate (1000 ng/ml).
"Cryoactivation" of Plasma Renin
To measure the reactivity of exogenous renin in plasma exposed to cold temperatures, peripheral venous blood was obtained from eight normotensive subjects. A control aliquot was frozen at -20°C for 5 days. Another aliquot was incubated in a shaker bath at -4°C and pH 7.4 for 5 days. Both aliquots were then incubated at 37°C and pH 7.4 for 60 minutes, and the concentrations of angiotensin I generated were measured (PRA). The reactivity of exogenous renin was compared in both aliquots by measuring the capacity of added renin (2.8 X 10 s GU/ml) to generate angiotensin I during a 60-minute incubation period. Again, the relatively low concentrations of angiotensin produced without added enzyme were subtracted from the total to determine the reactivity of exogenous renin. Renin substrate concentrations were also measured in both aliquots of plasma.
Effect of Acidification or Cold Exposure on Renin Inhibition by Fatty Acids
We have previously demonstrated that long chain, unsaturated fatty acids inhibit the renin reaction. 11 In a separate series of experiments, we evaluated the capacity of linoleic (18:2) acid and arachidonic (20:4) acid to inhibit renin after acidification. As we have previously described, fatty acids were taken up in hexane (10 mg/ml), and butylated hydroxyanisol was added to prevent oxidation (0.01 mg%). Each fatty acid (0.5 mg) was aliquoted to each of 16 tubes and was dried under vacuum. Phosphate buffer (0.75 ml) with lipid free human albumin (30 mg/ml) was added to each tube. Lipid free albumin alone does not affect the in vitro renin reaction. 1 ' Eight tubes with each fatty acid were then acidified according to the Skinner PRC procedure, and to control for an effect of dialysis itself the remaining eight tubes were dialyzed only against phosphate buffer at pH 7.4. Dialyzed fatty acids were added to renin substrate (1200 ng), and the fatty acid-renin substrate mixture was sonicated at room temperature for 90 seconds. Renin was then added (1.1 X 10~" GU/ml), and the rate of angiotensin production was compared in incubations containing fatty acid that had been dialyzed only at pH 7.4, fatty acid that had been exposed to pH 3.3, and control incubations containing only enzyme and substrate without fatty acid. We have previously reported that linoleic and arachidonic acids do not affect the recoveries of added angiotensin I, indicating that these fatty acids do not act as angiotensinases and do not interfere with the radioimmunoassay for angiotensin. 11 To determine if cold exposure affects the capacity of unsaturated fatty acids to inhibit renin, linoleic acid (aliquoted with albumin as described above) was incubated at -4°C for 5 days (n = 8). Control aliquots of linoleic acid were incubated at -20°C for 5 days (n = 8). Both cold-exposed (-4°C) and control aliquots of linoleic acid were added to renin (2.8 X 10 s GU/ml)-renin substrate (1000 ng/ml) as described above, and the final fatty acid concentration was 1 mg/ml. The concentrations of angiotensin I generated without fatty acid (n = 8), or with addition of coldexposed or control fatty acid, were measured after 30-and 60-minute incubations.
Analytical Methods
For all experiments, angiotensinase-free renin was prepared from human kidneys by the method of Haas.
1 ' Based on comparing the concentrations of angiotensin I generated in the presence of excess human substrate (5000 ng/ml) with a human renin standard obtained from the Medical Research Council (London, England), our concentrated enzyme preparation contained approximately 1.6 GU/ml. Homologous renin substrate was prepared from pooled plasma, obtained from normotensive women taking oral contraceptives, by ammonium sulfate precipitation between the molarity of 1.51 and 2.65 at pH 7.4. 20 The mean concentration of angiotensin I produced after incubation of substrate alone without enzyme (n = 10) was 1.2 ng/ml/hr ± 0.1 SE, and we attribute this to a renin contaminant. This "contaminant" was constant for all incubations and represents less than 2% of the concentrations of angiotensin generated with added renin. Chromatographic grade free fatty acids were obtained (Sigma Chemical, St. Louis, MO) and their purity was verified by gas liquid chromatography (GLC). For GLC, fatty acids were transmethylated with borontrifiuride-3-methanol (14% w/v) and benzene," and GLC of the methylated fatty acids was carried out using a Shimadzu GC-Mini 1 with an integrator.
Angiotensin I concentrations were measured in quadruplicate by the radioimmunoassay procedure of Haber et al.
M Dimercaprol (10 fi\ of a 2% solution/ml) and 8-hydroxyquinoline (10 ^1 of a 0.34 M solution/ml) were added to all incubations to inhibit converting enzyme activity. We have previously demonstrated that the recovery of angiotensin I added to plasma of normal subjects is essentially quantitative using this assay system, 10 indicating that the measurement of generated angiotensin I is not affected by differences of converting enzyme activity or nonspecific angiotensinase activity. To measure renin substrate, high concentrations of renin were added to plasma (0.2 GU/ml), and angiotensin I concentrations were measured after the reaction between added enzyme and endogenous substrate had proceeded to completion; angiotensin I concentrations after 3 and 6 hours incubation did not differ and were averaged.
For statistical analyses, either a paired or unpaired Student's t test was used. In instances where multiple comparisons were made, according to the Bonferroni modification of the t test, to accept an overall 0.05 significance level, a 0.01 significance level was required for each individual t test. 23 Consequently, for multiple comparisons, the designation of statistically significant differences will indicate a significance level of 0.05 or less.
Results

Acid "Activation" of Plasma Renin
Mean renin substrate concentration in control plasma dialyzed only at pH 7.4 was 966 ng/ml ± 74 SE. Substrate was almost totally denatured in plasma that had been acidified by dialysis (55 ng/ml ± 318 SE) and by addition of HC1 (33 ng/ml ± 3 SE), p > 0.02.
After addition of exogenous substrate, compared to that in control plasma dialyzed only at pH 7.4, PRA in each of eight subjects was higher after dialysis against the buffer at pH 3.3 ( fig. 1) . The mean PRA of 9.1 ng/ml/hr ± 0.8 SE after acid dialysis was significantly higher than the mean of 4.5 ng/ml/hr ± 0.3 SE in control plasma. Similarly, PRA increased significantly after acidification of plasma with dropwise addition of HC1 (6.6 ng/ml/hr ± 0.5 SE). However, PRA after acidification with HC1 was significantly lower than PRA measured after acidification of plasma by dialysis.
After addition of untreated plasma to renin-renin substrate, significantly less angiotensin was generated (p < 0.01) during both a 30-and a 60-minute incubation, than in control incubations containing only enzyme and substrate but no plasma ( fig. 2 ). Recoveries of standard angiotensin I in plasma (75 ng/ml) were virtually quantitative, indicating that lower concentrations of angiotensin measured with plasma cannot be attributed to angiotensinase activity, or to nonspecific interference with the radioimmunoassay. Unlike crude plasma, compared to the concentration of angiotensin generated in control incubations (72.5 ng/ml/hr ± 2.5 SE), no inhibition occurred after addition of plasma that had been acidified either by dialysis or by HCI ( fig. 3 ). However, after addition to renin-renin substrate, significantly less (p < 0.01) angiotensin was generated with plasma acidified by HCI (65.8 ng/ml/hr ± 2.7 SE) than with plasma acidified by dialysis (82.5 ng/ml/hr ± 2.3 SE).
Sephadex Fracrionation of Plasma
Addition of the substrate-free plasma fraction to renin-renin substrate significantly inhibited angiotensin production ( fig. 3 ). The capacity of this substratefree extract to inhibit renin after acid dialysis of whole plasma was then evaluated. Two aliquots of plasma from each of five subjects were passed over Sephadex: intact plasma and plasma exposed to acid dialysis. Again, during a 30-minute incubation, less angiotensin was generated with addition of renin-substrate-free plasma than in control incubations containing only enzyme and substrate ( fig. 4) . However, no inhibition occurred after addition of substrate-free plasma that had previously been acidified. During 60 minutes, compared to control incubations, significantly less angiotensin was produced with addition of the proteinfree fraction of both intact plasma and acidified plasma. However, significantly less inhibition occurred with the protein-free extract of acidified plasma. Thus, both crude plasma and a substrate-free extract of plasma inhibit the in vitro renin reaction. After addition to renin-renin substrate, relatively little or no inhibition occurred with acidified plasma or with a protein-free extract of plasma that had previously been exposed to pH 3.3. Taken together, these observations suggest that acidification of plasma denatures a non-protein renin inhibiting factor.
"Cryoactivation" of Plasma Renin
Mean plasma renin substrate in control plasma (1198 ng/ml ± 59 SE) and cold-exposed plasma (1105 ng/ml ± 66 SE) did not differ. The PRA increased in plasma from each of the subjects after cold exposure, and compared to that in control plasma (2.2 ng/ml/hr ± 0.4 SE) the mean was significantly elevated (p < 0.001) after cold exposure (5.6 ng/ml/hr ± 0.6 SE). After adding exogenous renin and adjusting for endogenous PRA, the rate of angiotensin I production was also significantly greater (p < 0.05) in coldexposed plasma (173 ng/ml/hr ± 16 SE) than in control plasma (134 ng/ml/hr ± 17 SE).
Effect of Acidification or Cold Exposure on Renin Inhibition by Fatty Acids
Compared to control incubations containing no fatty acid, after'dialysis at pH 7.4 both arachidonic and linoleic acids inhibited the concentrations of angiotensin I generated during a 60-minute incubation when added to renin-renin substrate (table 1) two fatty acids were initially dialyzed to pH 3.3 against a glycine buffer and then dialyzed back to pH 7.4, no significant inhibition occurred. However, the concentrations of linoleic acid measured by GLC after dialysis at pH 7.4 only (0.38 mg/ml ± 0.02 SE) or after initial dialysis to pH 3.3 (0.41 mg/ml ± 0.03 SE) did not differ. To determine if the loss of inhibitory activity after dialysis against the glycine buffer was related to acidification or to glycine itself, linoleic acid was also dialyzed to pH 3.3 against a citrate buffer and then back to pH 7.4. Again, after acidification by dialysis against the citrate buffer, linoleic acid did not inhibit angiotensin production. In a separate experiment incubation of linoleic acid at -4°C for 5 days did not impair its capacity to inhibit renin.
Discussion
Plasma renin activity increased both after acidification of plasma (either by dialysis against an acidic buffer or by dropwise addition of HC1) and after incubation of plasma at -4°C for 5 days. As anticipated, acidification of plasma denatured endogenous renin substrate, and the measurement of PRA required addition of exogenous substrate. After addition to renin-renin substrate, both untreated plasma and a renin-substrate-free extract of plasma inhibited the rate of angiotensin production. However, little or no inhibition occurred after addition of acidified plasma or the substrate-free extract of acidified plasma. These observations are consistent with the hypothesis that increased PRA after acidification of plasma is related to a loss of a nonprotein renin inhibiting factor. Compared to acidification by dialysis, PRA was lower and the enzymatic activity of exogenous renin was less in plasma acidified with addition of HC1, suggesting that acid dialysis more effectively impairs the capacity of plasma to inhibit renin. In separate experiments, the reactivity of exogenous renin increased in "cryoactivated" plasma, raising the possibility that loss of a renin inhibiting factor may also contribute to increased PRA after exposure of plasma to cold temperatures.
Activation of renin by acid dialysis has been reported to occur in kidney extracts, amniotic fluid, and plasma. 11 " 14 -"~" Although the molecular weight of renin is approximately 40,000 daltons, acid activation of renal renin has been attributed to conversion of a larger molecular weight renin to the smaller more active enzyme.
14 " However, Shulkes et al. 14 reported that the molecular weights of active and inactive renin did not differ in plasma or amniotic fluid. Day et al." found a high molecular weight renin (60,000) in amniotic fluid, in renal tumor extracts, in plasma from diabetic patients with nephropathy, and to a lesser extent in plasma of a relatively small percentage of patients with hypertension and proteinuria. The enzymatic activity of this "big renin" increased after acidification, although the molecular weight determined by sephadex gel filtration, did not change. 88 We have recently demonstrated that long chain, unsaturated fatty acids inhibit renin. 11 The current experiments with linoleic and arachidonic acids suggest that increased enzymatic activity of rcnin after acidification of plasma by dialysis may at least in part be related to loss of inhibition by fatty acids. In plasma, free fatty acids are bound to albumin, and consequently, in the present experiment, physiologic concentrations of lipid free albumin were added to fatty acids before dialysis. Although the binding of fatty acids to albumin is complex, when long chain, free fatty acids are incubated with albumin, the unbound concentrations of fatty acids increase as pH of the incubation medium is lowered." However, the recovery of linoleic acid was not decreased after acid dialysis, suggesting that acid dialysis may irreversibly affect fatty acid-protein binding rather than result in denaturation of fatty acid per se.
Other investigators have suggested that denaturation of a renin inhibitor also accounts for acid activation of renal renin. The enzymatic activity of purified hog and human renal renin does not increase after acidification, 50 ' S1 although acidification results in the production of 40,000 molecular weight hog renin from a partially purified 60,000 molecular weight enzyme. Levine et al. 31 reported that the enzymatic activity of partially purified hog renin is inhibited by addition of a crude kidney extract, and concluded that the purported activation of renin in crude unacidified kidney extract is due to the presence of an inhibitor that is destroyed by acidification. Leckie and McConnelP reported that after acidification, a larger proenzyme extracted from rabbit kidney dissociated into an active enzyme plus a renin inhibitor of molecular weight 13,000 daltons. Similar to our results in plasma, this inhibitor was inactivated after acidification either by dialysis or addition of HC1.
In apparent contrast to the present results, Sealey and Laragh 16 reported that the rate of angiotensin generation after addition of exogenous renin was not increased after storage of plasma at -20°C for 12 months. However, cryoactivation at -4°C for 5 days is considerably more effective than storage at -20°C, 16 and it is possible that small differences of renin reactivity could not be detected in measurements that had been obtained 1 year apart and in plasma that had been stored at -20°C. In the present experiment, we did observe greater reactivity of exogenous renin in cryoactivated plasma. Whether the relatively small increased reactivity of high concentrations of added renin is sufficient to totally account for increased PRA after cold exposure remains to be determined. Exposure of linoleic acid to cold temperatures did not alter its capacity to inhibit renin. This finding suggests that there may be additional inhibiting factors in plasma that are modified by these incubation conditions.
Trypsin," 1 "" pepsin, 14 and urinary kallikrein" activate plasma renin, and several neutral protease inhibitors have recently been reported to inhibit cryoactivation and partially inhibit acid activation." Plasma itself also contains proteinase inhibitors that limit the effect of proteolytic enzymes on renin." It has been suggested that cryoactivation and acid activation may reduce the Content of a neutral serine protease inhibitor normally present in plasma and that the liberated protease converts inactive prorenin to active renin. 3 * However, trypsin activation of plasma renin may not be entirely comparable to acid activation or cryoactivation. After cryoactivation of plasma, Noth et al.
M reported that renin activity increased further following subsequent incubation with trypsin. Trypsin activation occurs with both plasma substrate and tetradecapeptide substrate, whereas acid activation occurs only with plasma substrate." Furthermore, Slater et al." reported that trypsin activation also occurred with a 40,000 molecular weight renin separated by gel filtration, whereas acid activation did not occur with this relatively pure enzyme preparation. Thus, two mechanisms may contribute to renin activation, i.e., denaturation of a renin inhibitor and increased protease activity.
In summary, compared to that in buffer, the reactivity of added renin was decreased in untreated plasma and in a renin-substrate-free extract of plasma. However, the enzymatic activity of renin was not inhibited by acidified plasma. Renin reactivity was greater in plasma incubated at -4°C for 5 days than in plasma stored at -20°C. These observations are consistent with the hypothesis that plasma contains a renin inhibiting factor and that denaturation of circulating renin inhibitors contributes to acid activation and possibly to cryoactivation of PRA.
